Cardiovascular complications in COVID-19 patients with or without diabetes mellitus.
Temidayo A AbeObiora EgbucheJoseph IgweOpeyemi JegedeBivek WagleTitilope OlanipekunAnekwe OnwuanyiPublished in: Endocrinology, diabetes & metabolism (2020)
Mean age was 58 years. The unadjusted rates were higher in DM patients compared to non-diabetics for the composite cardiovascular end-point (73.2% vs. 40.6% p < .0001), acute myocarditis (36.6% vs. 15.5% p = .004), acute heart failure (25.3% vs. 5.6% p = .001), acute myocardial infarction (9.9% vs. 1.4% p = .03) and new-onset atrial fibrillation (12.7% vs. 1.4% p = .009). After controlling for relevant confounding variables, diabetic patients had higher odds of composite cardiovascular end-point, acute heart failure and new-onset atrial fibrillation.
Keyphrases
- acute heart failure
- heart failure
- atrial fibrillation
- acute myocardial infarction
- end stage renal disease
- percutaneous coronary intervention
- sars cov
- left atrial
- catheter ablation
- chronic kidney disease
- newly diagnosed
- oral anticoagulants
- liver failure
- left atrial appendage
- glycemic control
- left ventricular
- direct oral anticoagulants
- peritoneal dialysis
- prognostic factors
- intensive care unit
- risk factors
- coronary artery disease
- type diabetes
- metabolic syndrome
- venous thromboembolism
- hepatitis b virus
- weight loss
- aortic dissection
- insulin resistance